Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein

J Mol Biol. 1994 Jan 7;235(1):237-47. doi: 10.1016/s0022-2836(05)80030-0.

Abstract

A small RNA ligand with high affinity for the HIV-1 Rev protein, generated by the SELEX in vitro evolution method, was used in a series of chemical modification studies to aid in determining the secondary structure of the ligand, to detect which modifications interfere with the binding of the ligand to Rev, and to find those modifiable groups that are protected from attack when bound to the Rev protein. This SELEX RNA ligand, like the high-affinity binding site of the Rev-responsive element, seems to bind the Rev protein within or along the major groove. There are two major regions of the RNA that interact with the Rev protein, and these regions appear to be close in space. Additionally, this high-affinity ligand has been used as the basis for an additional "biased randomization" SELEX procedure, in an effort to gain comprehensive information on the RNA sequences and structural elements necessary for efficient binding to the Rev protein. This complementary experimental approach supports the structural conclusions of our chemical modification data.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Composition
  • Base Sequence
  • Computer Graphics
  • Consensus Sequence
  • DNA-Directed RNA Polymerases / metabolism
  • Gene Products, rev / metabolism*
  • HIV-1 / metabolism*
  • Ligands
  • Models, Molecular
  • Molecular Sequence Data
  • Nucleic Acid Conformation
  • Oligodeoxyribonucleotides
  • RNA, Viral / chemistry*
  • RNA, Viral / metabolism*
  • Transcription, Genetic
  • Viral Proteins
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • Gene Products, rev
  • Ligands
  • Oligodeoxyribonucleotides
  • RNA, Viral
  • Viral Proteins
  • rev Gene Products, Human Immunodeficiency Virus
  • bacteriophage T7 RNA polymerase
  • DNA-Directed RNA Polymerases